Hudson Bay Capital Management’s Sana Biotechnology SANA Stock Holding History

Hudson Bay Capital Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$28.8K	Buy	+10,000	New	+$39.4K	﹤0.01%	1310

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Hudson Bay Capital Management's SANA Position: Q1 2026 in Review

Hudson Bay Capital Management opened a new position in Sana Biotechnology (SANA) in Q1 2026: 10,000 shares worth $28.8K. The stake represents ﹤0.01% of the portfolio and ranks #1310 among its holdings.

202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

Hudson Bay Capital Management held 10,000 shares of Sana Biotechnology worth $28.8K as of Q1 2026.
Sana Biotechnology was a new Hudson Bay Capital Management position in Q1 2026.
Sana Biotechnology made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #1310 holding.
202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.